Deutsche Bank’s CAMP4 Therapeutics CAMP Stock Holding History
Bought
Maintained
Sold
Other funds holding CAMP
Deutsche Bank's CAMP Position: Q3 2026 in Review
Deutsche Bank reduced its CAMP4 Therapeutics (CAMP) stake by 12% in Q3 2026, selling an estimated $16.1K and leaving 27,670 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #3328.
Deutsche Bank first reported a position in CAMP in Q1 2025 and has held it in 3 quarters since. The position peaked at $138K in Q2 2026. 69 funds tracked by Wall St. Rank hold CAMP as of Q3 2026.
- Deutsche Bank held 27,670 shares of CAMP4 Therapeutics worth $112K as of Q3 2026.
- Deutsche Bank sold 3,919 CAMP4 Therapeutics shares in Q3 2026, an estimated $16.1K.
- CAMP4 Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #3328 holding.
- Deutsche Bank first reported a position in CAMP4 Therapeutics in Q1 2025 and has held it in 3 quarters since.
- Deutsche Bank's CAMP4 Therapeutics position peaked at $138K in Q2 2026.
- 69 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q3 2026.
Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.